Cancer Webinars
Stay informed on developments in cancer and oncology diagnosis, prevention and treatment through these curated webinars. As the race toward a cure for cancer continues, advances in cancer research are constantly revealed as innovation in the field of oncology progresses.
Show More
-
APR 02, 2025 | 11:00 AM
Join this year's poster presenters in the Poster Hall during the Poster Networking Hour, Wednesday, September 20th, from 10:00 AM –11:00 AM PDT , to chat live about their posters a...
MAR 27, 2025 | 1:00 PM
C.E. CREDITS
El cáncer de pulmón sigue siendo una de las principales causas de mortalidad relacionada con el cáncer en todo el mundo con altas tasas debido al diagnóstico en etapa tardía. Este seminario...
MAR 27, 2025 | 9:00 AM
Trees get diseases too! For the molecular research scientists that identify and provide management recommendations for plant diseases that impact trees and other woody plants, tools specific...
MAR 26, 2025 | 8:00 AM
Single-cell analysis is a new and rapidly growing field that is shedding new insight into the cellular mechanisms behind the pathogenesis and treatment of infectious diseases and cancer. Cel...
MAR 19, 2025 | 8:00 AM
Join us for an enlightening session on the latest advancements in organoid research and drug discovery! Discover transformative applications, emerging trends, and common challenges in organo...
MAR 17, 2025 | 8:00 AM
This session provides an introduction to the MiSeq i100 Series, the simplest, fastest benchtop sequencer. Giving a brief overview of the revolutionary technology that's been built into the n...
MAR 12, 2025 | 8:00 AM
For large-scale enrichment and isolation of immune cells or stem cells for cell therapy applications, common cell purification platforms separate cells based on a single surface antigen. Enr...
MAR 11, 2025 | 10:00 AM
C.E. CREDITS
Variant interpretation in cancer susceptibility genes presents unique challenges due to issues such as phenocopies, incomplete/age-related penetrance and the mortality associated with the ph...
MAR 07, 2025 | 1:00 PM
C.E. CREDITS
Ovarian cancer remains a significant challenge in women's health, with high mortality rates due to late-stage diagnosis. This webinar aims to provide healthcare professionals with an in-...
MAR 07, 2025 | 11:30 AM
C.E. CREDITS
El cáncer de ovario sigue siendo un desafío importante para la salud de las mujeres, con altas tasas de mortalidad debido al diagnóstico en etapa tardía. Este sem...
FEB 26, 2025 | 8:00 AM
Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leverag...
FEB 18, 2025 | 8:00 AM
Join us for an enlightening webinar with Dr. Bruno Paiva, where we will delve into the Next Generation Flow ™ technology. This technology, known for its high sensitivity and standardiz...
FEB 18, 2025 | 8:00 AM
Developing and validating RUO targeted quantitative methods for clinical applications presents many challenges to researchers. Resulting LC-MSn methods cover diverse molecular classes of com...
FEB 12, 2025 | 8:00 AM
The SH800 Cell Sorter by Sony is a versatile solution designed to deliver exceptional sorting performance across a wide array of applications. Tailored to meet diverse user needs, it incorpo...
FEB 05, 2025 | 8:00 AM
The advent of the spatial omics era has enabled researchers to acquire vast amounts of transcriptomics and proteomics data. The abundance of a transcript, however, does not necessarily displ...
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
DEC 04, 2024 | 8:30 AM
Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated exp...
NOV 20, 2024 | 8:00 AM
Single-cell technology has revolutionized the field of biological research by enabling the analysis of individual cells, providing unprecedented insights into cellular heterogeneity and func...
NOV 20, 2024 | 8:00 AM
The Genome Diagnostics lab of the Human Genetics Dept. at Radboud UMC provides rapid whole exome sequencing since 2017, with a max turnaround time of 15 days (from sample to report). With th...
NOV 19, 2024 | 8:00 AM
Cimeio Therapeutics is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP). Gene editing is used to introduce single nucle...
NOV 19, 2024 | 8:00 AM
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
NOV 14, 2024 | 12:00 PM
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adver...
NOV 14, 2024 | 12:00 PM
C.E. CREDITS
Single-cell sequencing (scSeq) is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often mask...
NOV 13, 2024 | 11:00 AM
The STELLARIS confocal platform offers significant advancements for high-multiplex strategies, integrating a tunable white light laser (WLL) with an excitation range from 440 nm to 790 nm an...
NOV 13, 2024 | 10:00 AM
C.E. CREDITS
In 2022, there were approximately 1.4 million new cases of prostate cancer reported globally and over 397,000 deaths reported globally. PSA testing can have significant value in detecting me...
NOV 07, 2024 | 11:00 AM
Fluorescent dyes are molecules that are widely used in fundamental research, industrial R&D and manufacturing, medicine, and other industries. To successfully implement all advantages of...
NOV 07, 2024 | 8:00 AM
High resolution surveys of the tumor microenvironment (TME) are needed to obtain a holistic portrait of the genetic, epigenetic, and cellular factors contributing to cancer progression. To t...
